Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs.

Dalwadi DA, Ozuna L, Harvey BH, Viljoen M, Schetz JA.

Pharmacol Rev. 2018 Jul;70(3):684-711. doi: 10.1124/pr.117.013706. Review.

PMID:
29945900
2.

Comparative Exploration of the Structure-Activity Space of Cloned α-Like Octopamine Receptors from a Marine and a Terrestrial Arthropod.

Dalwadi DA, Schetz JA.

Mol Pharmacol. 2017 Sep;92(3):297-309. doi: 10.1124/mol.117.108456. Epub 2017 Jun 29.

PMID:
28663279
3.

The dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites.

Huang R, Chen Z, Dolan S, Schetz JA, Dillon GH.

Neuropharmacology. 2017 Jul 15;121:167-178. doi: 10.1016/j.neuropharm.2017.04.038. Epub 2017 Apr 27.

4.

Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia.

Dalwadi DA, Kim S, Schetz JA.

Neurochem Int. 2017 May;105:21-31. doi: 10.1016/j.neuint.2017.02.003. Epub 2017 Feb 8.

5.

Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.

Dalwadi DA, Kim S, Amdani SM, Chen Z, Huang RQ, Schetz JA.

Pharmacol Res. 2016 Aug;110:10-24. doi: 10.1016/j.phrs.2016.04.028. Epub 2016 May 6.

6.

In vitro and in vivo evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[(11) C]methoxybenz-amide, a positron emission tomography (PET) radioligand for dopamine D4 receptors, in rodents.

Leopoldo M, Selivanova SV, Müller A, Lacivita E, Schetz JA, Ametamey SM.

Chem Biodivers. 2014 Sep;11(9):1298-308. doi: 10.1002/cbdv.201400178.

PMID:
25238073
7.

Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Saunders C, Siuta M, Robertson SD, Davis AR, Sauer J, Matthies HJG, Gresch PJ, Airey D, Lindsley CW, Schetz JA, Niswender KD, Veenstra-Vanderweele JM, Galli A.

Neurochem Int. 2014 Jul;73:113-121. doi: 10.1016/j.neuint.2013.09.015. Epub 2013 Sep 30.

8.

The HIV antiretroviral drug efavirenz has LSD-like properties.

Gatch MB, Kozlenkov A, Huang RQ, Yang W, Nguyen JD, González-Maeso J, Rice KC, France CP, Dillon GH, Forster MJ, Schetz JA.

Neuropsychopharmacology. 2013 Nov;38(12):2373-84. doi: 10.1038/npp.2013.135. Epub 2013 May 24.

9.

Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor.

Ericksen SS, Cummings DF, Teer ME, Amdani S, Schetz JA.

J Pharmacol Exp Ther. 2012 Aug;342(2):472-85. doi: 10.1124/jpet.112.193979. Epub 2012 May 15.

10.

Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.

Lacivita E, De Giorgio P, Lee IT, Rodeheaver SI, Weiss BA, Fracasso C, Caccia S, Berardi F, Perrone R, Zhang MR, Maeda J, Higuchi M, Suhara T, Schetz JA, Leopoldo M.

J Med Chem. 2010 Oct 28;53(20):7344-55. doi: 10.1021/jm100925m.

11.

Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes.

Cummings DF, Canseco DC, Sheth P, Johnson JE, Schetz JA.

Bioorg Med Chem. 2010 Jul 1;18(13):4783-92. doi: 10.1016/j.bmc.2010.05.017. Epub 2010 May 15.

12.

Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Cummings DF, Ericksen SS, Goetz A, Schetz JA.

J Pharmacol Exp Ther. 2010 Jun;333(3):682-95. doi: 10.1124/jpet.109.164962. Epub 2010 Mar 9. Erratum in: J Pharmacol Exp Ther. 2010 Nov;335(2):518.

13.

Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity.

Cummings DF, Ericksen SS, Schetz JA.

J Neurochem. 2009 Jul;110(1):45-57. doi: 10.1111/j.1471-4159.2009.06103.x. Epub 2009 Apr 16.

14.

Cannabinoids inhibit zebra mussel (Dreissena polymorpha) byssal attachment: a potentially green antifouling technology.

Angarano MB, McMahon RF, Schetz JA.

Biofouling. 2009;25(2):127-38. doi: 10.1080/08927010802592743.

PMID:
19037826
15.

Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding.

Ericksen SS, Cummings DF, Weinstein H, Schetz JA.

J Pharmacol Exp Ther. 2009 Jan;328(1):40-54. doi: 10.1124/jpet.108.141531. Epub 2008 Oct 10.

16.

Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation.

Chang CW, Poteet E, Schetz JA, Gümüş ZH, Weinstein H.

Neuropharmacology. 2009;56 Suppl 1:213-25. doi: 10.1016/j.neuropharm.2008.07.049. Epub 2008 Aug 13.

17.

Protein expression in the Drosophila Schneider 2 cell system.

Schetz JA, Shankar EP.

Curr Protoc Neurosci. 2004 Sep;Chapter 4:Unit 4.16. doi: 10.1002/0471142301.ns0416s27.

PMID:
18428600
19.

A prototypical Sigma-1 receptor antagonist protects against brain ischemia.

Schetz JA, Perez E, Liu R, Chen S, Lee I, Simpkins JW.

Brain Res. 2007 Nov 21;1181:1-9. Epub 2007 Sep 12.

20.
21.

Allosteric modulation of dopamine receptors.

Schetz JA.

Mini Rev Med Chem. 2005 Jun;5(6):555-61. Review.

PMID:
15974933
23.

Dopamine receptor microdomains involved in molecular recognition and the regulation of drug affinity and function.

Floresca CZ, Schetz JA.

J Recept Signal Transduct Res. 2004 Aug;24(3):207-39. Review. Erratum in: J Recept Signal Transduct Res. 2006;26(3):213-23.

PMID:
15521362
24.

Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain.

Kortagere S, Gmeiner P, Weinstein H, Schetz JA.

Mol Pharmacol. 2004 Dec;66(6):1491-9. Epub 2004 Sep 24.

PMID:
15448188
25.
26.

New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea.

Hu JF, Schetz JA, Kelly M, Peng JN, Ang KK, Flotow H, Leong CY, Ng SB, Buss AD, Wilkins SP, Hamann MT.

J Nat Prod. 2002 Apr;65(4):476-80.

PMID:
11975483
27.
28.
30.

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.

Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB.

Neuropsychopharmacology. 1999 Jun;20(6):612-27.

31.

Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.

Schetz JA, Chu A, Sibley DR.

J Pharmacol Exp Ther. 1999 May;289(2):956-64.

PMID:
10215675
32.

Dopamine D2-receptor isoforms expressed in AtT20 cells inhibit Q-type high-voltage-activated Ca2+ channels via a membrane-delimited pathway.

Wolfe SE, Howard DE, Schetz JA, Cheng CJ, Webber R, Beatty DM, Chronwall BM, Morris SJ.

J Neurochem. 1999 Feb;72(2):479-90.

33.

Adenosine receptor mediates motility in human melanoma cells.

Woodhouse EC, Amanatullah DF, Schetz JA, Liotta LA, Stracke ML, Clair T.

Biochem Biophys Res Commun. 1998 May 29;246(3):888-94.

PMID:
9618307
34.
35.

Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats.

Schetz JA, Calderon SN, Bertha CM, Rice K, Porreca F.

J Pharmacol Exp Ther. 1996 Dec;279(3):1069-76.

PMID:
8968326
36.

Pharmacology of the high-affinity apamin receptor in rabbit heart.

Schetz JA, Anderson PA.

Cardiovasc Res. 1995 Nov;30(5):755-62.

PMID:
8595623
37.

Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.

Schetz JA, Mayr CA, Taylor JE, Rosenblatt M, Chorev M, Davis TP.

J Pharmacol Exp Ther. 1995 Sep;274(3):1456-62.

PMID:
7562522
38.

Glycosylation patterns of membrane proteins of the jellyfish Cyanea capillata.

Schetz JA, Anderson PA.

Cell Tissue Res. 1995 Feb;279(2):315-21.

PMID:
7534653
39.

Pattern recognition metric for comparison of protein structures based on amino acid sequences.

Schetz JA.

Methods Enzymol. 1994;240:667-723. No abstract available.

PMID:
7823853
40.

A Reevaluation of the Structure in the Pore Region of Voltage-Activated Cation Channels.

Schetz JA, Anderson P.

Biol Bull. 1993 Dec;185(3):462-466. doi: 10.2307/1542486.

PMID:
29300621

Supplemental Content

Loading ...
Support Center